- Viking Therapeutics (VKTX +1.5%) enters into a common stock purchase agreement with Aspire Capital Fund, LLC under which Aspire will buy up to $12.5M in stock over the next 30 months at market prices at Viking's discretion.
- Aspire has made an initial purchase of $500K in shares at $1.50. Net proceeds will be used for general corporate purposes.
Viking Therapeutics inks $12.5M stock purchase deal with Aspire Capital
Recommended For You
About VKTX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
VKTX | - | - |
Viking Therapeutics, Inc. |